Catalyst
Slingshot members are tracking this event:
Ad Comm review on July 12 for Amgen's Humira biosimilar ABP 501
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AMGN | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 13, 2016
Occurred Source:
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM510293.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Humira, Abp 501
